全基因组测序在Diamond-Blackfan贫血综合征患者中鉴定出2个新非编码变异
该研究报告2例既往靶向基因panel、核型分析、染色体断裂分析及全外显子测序均阴性的Diamond-Blackfan贫血综合征(DBAS)病例,临床全基因组测序(WGS)初始阴性,深度重分析发现RPS7母源剪接变异(c.-19G>C)和RPS19深内含子新发变异(c.172+350C>T),RNA测序证实两者均有功能损害。
要点
- 临床WGS初始阴性后深度重分析可发现DBAS相关非编码变异。
- RPS7 c.-19G>C母源变异家系中多名母系亲属经级联检测携带同一变异。
- 例1经未携带该变异的同胞供者造血干细胞移植成功治愈先天性贫血。
核心结论
- 本研究鉴定出RPS7和RPS19两个新非编码变异,并强调WGS在加速罕见遗传病诊断和改善诊疗中的临床实用性,尤其在及时治疗决策至关重要时。
研究设计与样本
- 报告2例既往遗传学检测(靶向基因panel、核型分析、染色体断裂分析、全外显子测序)阴性的DBAS病例,行临床全基因组测序并深度重分析,辅以RNA测序分析。
主要发现
- 家系1发现母源遗传的RPS7第一非编码外显子末端剪接变异(NM_001011.4,c.-19G>C),家系2发现RPS19深内含子新发变异(NM_001022.4,c.172+350C>T)。
- 家系1经级联检测发现多名母系亲属携带同一变异,临床表现为不同程度贫血和红细胞腺苷脱氨酶活性升高。
- RNA测序分析显示两个非编码变异均有有害功能后果。
- 例1接受未携带该变异的同胞供者造血干细胞移植,成功治愈先天性贫血。
临床怎么用
- 原文结论强调WGS在加速罕见遗传病诊断和改善诊疗方面的临床实用性,尤其在及时治疗决策至关重要时。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Diamond-Blackfan anemia syndrome (DBAS) is a rare congenital disorder with variable penetrance and expressivity and is characterized by pure red cell aplasia that typically manifests as early-onset chronic macrocytic or normocytic anemia and is often associated with other congenital anomalies. DBAS is etiologically heterogeneous with >20 known DBAS-associated genes that encode small and large ribosomal protein subunits and an inheritance pattern that is largely autosomal dominant or sporadic. We report 2 DBAS cases with previous negative genetic testing, which included targeted gene panels, karyotype analysis, chromosome breakage analysis, and whole exome sequencing. Although clinical whole genome sequencing (WGS) was initially negative, in-depth reanalysis identified 2 novel noncoding variants in the RPS gene family, namely a maternally inherited splicing variant at the end of the first noncoding exon in RPS7 (NM_001011.4, c.-19G>C) in family 1 and a deep intronic de novo variant in RPS19 (NM_001022.4, c.172+350C>T) in family 2. In family 1, several maternal relatives were identified who shared the same variant through cascade testing; clinically, they exhibited variable degrees of anemia and elevated erythrocyte adenosine deaminase activity, a marker for DBAS. RNA sequencing analysis demonstrated deleterious functional consequences for both noncoding variants. In case 1, hematopoietic stem cell transplant with an unaffected matched sibling donor who did not carry the variant successfully cured the congenital anemia. This study identified novel noncoding variants and underscores the clinical utility of WGS in accelerating diagnosis and improving care for rare genetic disorders, particularly when timely treatment decisions are critically important.
引用
- Wen T, Boyden SE, Hocutt CM, et al. Identification of 2 novel noncoding variants in patients with Diamond-Blackfan anemia syndrome by whole genome sequencing. Blood Adv. 2025. PMID: 40029997. doi:10.1182/bloodadvances.2024015347
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。